These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 5867570

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Epsilon aminocaproic acid--a dangerous weapon.
    Ratnoff OD.
    N Engl J Med; 1969 May 15; 280(20):1124-5. PubMed ID: 5813521
    [No Abstract] [Full Text] [Related]

  • 6. Fibrinolytic activity in hemophilia and the use of epsilon-aminocaproic acid.
    Ritz ND.
    N Y State J Med; 1965 Dec 01; 65(23):2914-25. PubMed ID: 5320118
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Essential hematuria and its treatment with fibrinolysis inhibitors].
    Zhila VV.
    Vrach Delo; 1968 Feb 01; 2():82-5. PubMed ID: 5669369
    [No Abstract] [Full Text] [Related]

  • 12. [Urinary incidents in the treatment of hematuria in hemophiliacs with epsilon-aminocaproic acid].
    Goudemand M, Parquet-Gernez A, Deconninck B.
    Lille Med; 1968 Apr 01; 13(4):408-12. PubMed ID: 5684775
    [No Abstract] [Full Text] [Related]

  • 13. Epsilon-aminocaproic acid (E-ACA) as a therapeutic agent based on 5 year's clinical experience.
    Nilsson IM, Andersson L, Björkman SE.
    Acta Med Scand Suppl; 1966 Apr 01; 448():1-46. PubMed ID: 5221699
    [No Abstract] [Full Text] [Related]

  • 14. [Latent hemorrhagic diathesis as cause of gynecologic hemorrhages].
    Schwenke H.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966 Apr 01; 85(1):74-80. PubMed ID: 4165543
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Fibrinolytic and "consumption" coagulopathy. Therapeutic and clinical remarks].
    Dyk T.
    Pol Tyg Lek; 1969 Sep 25; 24(34):1318-22. PubMed ID: 5308022
    [No Abstract] [Full Text] [Related]

  • 18. [The effect of hydrocortisone and epsilon-aminocaproic acid on the course of hemorrhagic syndrome in vitamin C deficiency].
    Oĭvin VI, Sushkevich GN, Khnychev SS.
    Patol Fiziol Eksp Ter; 1969 Sep 25; 13(2):51-4. PubMed ID: 5382863
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical significance of the use of antifibrinolytic agents].
    Czuczor H, Vecsey D, Bánkuti P.
    Orv Hetil; 1969 Apr 27; 110(17):966-9. PubMed ID: 5305356
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.